SUBSCRIBE
SUBSCRIBE
Kate Goodwin

Kate Goodwin

Contributing Writer | News & Features

Kate Goodwin hails from a background primarily in marketing. A passion for health sciences and writing led her to the biopharma news world, and she’s never looked back. She’s been writing for BioSpace for more than two years with a focus on cutting edge research, Alzheimer’s disease and pediatrics. Her free time is filled by her husband, children, Beagles, books, crochet and creative writing. She can be reached at kate.goodwin@biospace.com.

Detecting Cancer Earlier – UK to Pilot Blood Test with 165,000 Patients
California-based Grail aims to alter the devastating trajectory of cancer mortality with the addition of one simple blood test.
November 30, 2020
 · 
3 min read
 · 
Kate Goodwin
Biotech Bay
Biopharma Money on the Move: November 18-24
Find out which biopharma companies are raking in cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
November 24, 2020
 · 
6 min read
 · 
Kate Goodwin
BioCapital
Antitrust Panel Sets Sights on Big Pharma for Next Target
Following a year-long probe into tech giants Amazon, Apple, Facebook, and Google, the House Judiciary antitrust subcommittee has its next target in its sights – big pharma.
November 24, 2020
 · 
3 min read
 · 
Kate Goodwin
Business
New Manufacturing Innovator Launches to Change the Way Medicine is Made
New company looks to revolutionize the biopharmaceutical manufacturing process to make cutting-edge drugs more accessible.
November 23, 2020
 · 
2 min read
 · 
Kate Goodwin
The FDA approval of Zokinvy is providing new hope
FDA
Giving the Gift of Time, FDA Approves First Treatment, Zokinvy, for Rare Childhood Aging Diseases
Eiger’s Zokinvy is the first-ever approved treatment for children with Huchinson-Gilford Progeria Syndrome and processing-deficient Progeroid Laminopathies.
November 23, 2020
 · 
2 min read
 · 
Kate Goodwin
Hugh Young Rienhoff, Jr., M.D., CEO at Imago BioSc
Biotech Beach
In Fight Against Blood Cancer, Imago Doubles Down with $80 Million Series C
Funding raised will be used to take lead candidate into Phase III clinical trials.
November 19, 2020
 · 
2 min read
 · 
Kate Goodwin
Photo courtesy of Umoja Biopharma.
Business
Innovative New Biotech Aims to Bring More Effective Immunotherapies to Patients
Immunotherapies are about to get safer, more effective, and even more accessible with the new biotech’s novel approach.
November 17, 2020
 · 
3 min read
 · 
Kate Goodwin
Deals
Biopharma Money on the Move: November 11-17
Find out which biopharma companies are raking in cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
November 17, 2020
 · 
4 min read
 · 
Kate Goodwin
Photo courtesy of Seattle Children's Therapeutics.
Business
Curing Our Kids: Seattle Children’s Launches Next-Gen Therapeutics Non-Profit
The word “children” may come second in their name, but Seattle Children’s Hospital is proving they truly put children first.
November 17, 2020
 · 
9 min read
 · 
Kate Goodwin
Photo courtesy of D3 Bio.
Business
Pharma Veteran Rounds Up $200 Million for His Own Biotech
George Chen left AstraZeneca after seven years to pursue his own line of oncology and immunology R&D.
November 17, 2020
 · 
2 min read
 · 
Kate Goodwin
Policy
France’s Medicine Watchdog Indicted Over Sanofi’s Birth Defect-Causing Drug Depakine
Sanofi was formally charged over Depakine, its epilepsy drug, for not taking action when they first discovered the fetal risks when taken by pregnant women.
November 13, 2020
 · 
3 min read
 · 
Kate Goodwin
Business
Can Pfizer’s COVID-19 Vaccine End the Pandemic? BioNTech’s CEO Believes So
The BioNTech scientist said his vaccine can “bash the virus over the head”.
November 13, 2020
 · 
2 min read
 · 
Kate Goodwin
Business
Sunshine Vitamin Could Help Boost Immunity in Fight Against COVID-19
A recent study found that Vitamin D deficiency may be associated with an increased COVID-19 risk.
November 13, 2020
 · 
4 min read
 · 
Kate Goodwin
Business
Biopharma Money on the Move: November 4-10
Find out which biopharma companies are raking in cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
November 10, 2020
 · 
5 min read
 · 
Kate Goodwin
Affimed CEO Adi Hoess, M.D., Ph.D/courtesy of Affi
Business
Affimed Joins Forces with Roivant in Fight Against Cancer
Affimed receives $60 million up front with potential for up to $2 billion more in partnership deal with Roivant Sciences.
November 10, 2020
 · 
2 min read
 · 
Kate Goodwin
Load More